Tyco sees global prospects in $3.1 billion Bard deal
This article was originally published in Clinica
Tyco International, owner of significant brand names in the device industry such as US Surgical and Mallinckrodt, is to become the largest company in the market following its agreed bid to purchase CR Bard for $3.1 billion in shares. Bard made sales of $1.1 billion in 2000, with Tyco turning over some $6.5 billion from healthcare activities to September 2000. It closed the acquisition of $2.5 billion turnover company Mallinckrodt after the end of the financial year.